Hemophilia
Conditions
Interventions
Test group:Congenital hemophilia: Using XueYou-Mixture and Promoting Hepatocyte Growth Factor (PHGF)
Test group:Acquired hemophilia: Using non-hormonal immunity inhibitor (Thymosins, cyclophosphamide, Compound?Glycyrrhizin, Mycophenloate Mofetil Tablets)
Control group:Using FVIII /FIX
Sponsors
Shaanxi Yida Hemophilia Institute affiliated Xi’an Xincheng Yida Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 85 Years
Inclusion criteria
Inclusion criteria: 1. Meet the clinical-defined hemophilia criteria; 2. Agree to use integrated chinese western therapy for improving patient's own activity of FVIII/FIX and disuse recombinant coagulation factor during the experiment; 3. sign informed conset.
Exclusion criteria
Exclusion criteria: 1. Patients with hemorrhagic disease of non-hemophlia such as von willebrand disease and secondary recombinant FVIII/FIX deficiency(liver cirrhosis; 2. Patients with mortal danger; 3. Allergic constitution or allergic to this decoction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| APTT test;The activity of FVIII /FIX;FVIII /FIX: Antibody;Bleeding rate, mortality rate, disability rate; | — |
Countries
China
Contacts
Public ContactLiu Shanxi
Shaanxi Yida Hemophilia Institute affiliated Xi’an Xincheng Yida Hospital
Outcome results
None listed